MAPT and Alzheimer disease: In line with this, T22 immunoreactivity in human brain extracts largely mirrored that of “total” Tau antibodies, e.g. Tau-12 or K9JA Dako, such that the majority of the T22 signal originated from detection of Tau monomers accompanied by faint detection of high-MW Tau in AD brain samples (Supp.